arrow
R

Robert Forbrig

LMU University Hospital
H指数:23
被引数:1,360

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Limited Predictability of Traumatic Intracranial Hemorrhage from Routine Pre-CT Clinical Variables in Older Adults with Low-Energy Falls: A Systematic Benchmarking Study in a Retrospective Bicentric Cohort

老年低能量跌倒患者创伤性颅内出血的有限可预测性:基于回顾性双中心队列的系统性基准研究

2026-09-040
OA
PET RANO 1.0 vs RANO 2.0 criteria for trial eligibility in IDH-wildtype glioblastoma: A retrospective, comparative study

PET RANO 1.0与RANO 2.0标准在IDH野生型胶质母细胞瘤临床试验入组资格中的应用:一项回顾性比较研究

2026-08-140
PRE
Defining measurable disease as inclusion criterion in glioblastoma trials – a retrospective, comparative study of PET RANO 1.0 vs. RANO 2.0 criteria after radiotherapy and first progression

将可测量病灶定义为胶质母细胞瘤试验的纳入标准——放射治疗和首次进展后PET RANO 1.0与RANO 2.0标准的回顾性比较研究

2026-04-140
PRE
AI-based assessment of brain volume decrease after treatment with stereotactic radiosurgery versus whole brain radiotherapy

基于人工智能的治疗后立体定向放射外科与全脑放射治疗对脑容量减少的评估

2026-01-100
PRE
Clinical potential of [18F]FET PET in patients with circumscribed astrocytic glioma

[18F]FET PET在局限性星形细胞胶质瘤患者中的临床潜力

2025-11-180
OAAI
Defining measurable disease as inclusion criterion in glioblastoma trials - a retrospective, comparative study of PET RANO 1.0 vs. RANO 2.0 criteria after radiotherapy and at first progression

将可测量病灶作为胶质母细胞瘤试验的纳入标准——放疗后及首次进展时PET RANO 1.0与RANO 2.0标准的回顾性比较研究

2025-11-010
OAAI
Measurable disease for response assessment in IDH-mutant glioma - a comparison of MRI-based (RANO 2.0) versus PET-based (PET RANO 1.0) assessment

IDH突变型胶质瘤中可测量病灶的疗效评估——基于MRI(RANO 2.0)与基于PET(PET RANO 1.0)评估的比较

2025-11-010
OAAI
Prognostic significance of PET RANO 1.0-based response assessment in patients with newly diagnosedIDH-wildtype glioblastoma

基于PET RANO 1.0的反应评估在 newly diagnosed IDH-wildtype glioblastoma 患者中的预后意义

2025-11-010
OAAI
CLINICAL UTILITY OF [18F]FET PET IN PATIENTS WITH CIRCUMSCRIBED ASTROCYTIC GLIOMA

[18F]FET PET在局限性星形细胞胶质瘤患者中的临床应用价值

2025-10-010
OA